Citations

Clear

5 citation(s) found for "Al-Salahat, Ali".

Palliative Care Consultation in Ischemic Stroke: Nationwide Disparities and Predictors (P1-13.013)
Asghar, Muhammad Roshan , Al-Salahat, Ali, Hall, A , Bawaneh, Saif, Singh, Jagkirat , Sharma, Rohan, Al‐Salahat, Ali , Bawaneh, Saif, Verma, Himanshu , Rahimian, Nasrin

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216682 Get It

Readmission Patterns and Predictors in Spinal Cord Infarction: Insights from a Nationwide Analysis (P10-5.013)
Bawaneh, Saif, Al-Salahat, Ali, Asghar, Muhammad Roshan, Hall, A , Sharma, Rohan, Bawaneh, Saif, Al‐Salahat, Ali

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216021 Get It

Persistent Trigeminal Artery as a Rare Conduit for Embolic Stroke (P1-5.012)
Bawaneh, Saif, Al-Salahat, Ali, Prajapati, Mittal, Asghar, Muhammad Roshan, Sharma, Rohan, Kapoor, Nidhi , Al‐Salahat, Ali , Prajapati, Mittal S

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216256 Get It

Abstract WP163: Predictors Of All-Cause Readmissions After Spinal Cord Infarctions: A Nationwide Analysis
Bawaneh, Saif, Asghar, Muhammad Roshan, Al-Salahat, Ali, Hall, Alexander, Sharma, Rohan, Bawaneh, Saif, Al‐Salahat, Ali , Hall, A

Mayo Clinic

Stroke | January 29, 2026 | Volume: 57 | Issue: Suppl_1 | Pages: No page available

10.1161/str.57.suppl_1.wp163 Get It

Introduction: Spinal cord infarction (SCI) is a rare but serious neurological condition that accounts for 1-2% of all ischemic strokes and can lead to significant disability. Despite its clinical importance, existing studies are limited by small sample sizes that lack national generalizability, and little is known about post-discharge events such as hospital readmissions. We aimed to evaluate factors associated with all-cause hospital readmissions among hospitalizations with primary diagnosis of SCI, utilizing the Nationwide Readmissions Database (NRD). Methods: NRD data were abstracted from 2016 to 2022 including all hospitalizations of adult patients (≥18 years) with a primary diagnosis of SCI. Multiple-predictor logistic regression models were estimated to assess the association of demographic and clinical variables with all-cause 90-day readmissions. We included specific comorbidities often used in comorbidity scoring systems and added conditions or complications that are known to be associated with SCI. Statistically significant covariates from the unadjusted model were retained in the multiple-predictor model. Odds ratios (OR) with associated 95% Confidence intervals (CI) and p-values were reported. Results: From 2016 to 2022, there were an estimated 3321 hospitalizations with a primary diagnosis of SCI, out of which 27% (95% CI: 24-30%) were readmitted within 90 days. Demographic factors that were associated with lower odds of readmission included private insurance (vs. Medicare) and high-income quartile (Fig. 1). [AH1] [AAs2] Clinical factors that were associated with increased odds of readmission included autonomic dysfunction (OR = 5.44, 95% CI: 1.86 to 15.94), renal disease (OR = 3.57, 95% CI: 1.83 to 6.96), liver disease (OR = 2.40, 95% CI: 1.34 to 4.32), full clinical associations shown in Figure 2. Conclusion: We identified several clinical and demographic factors that were significantly associated with increased all-cause readmissions after SCI hospitalizations. Autonomic dysfunction and renal disease were among the top predictors of readmissions. We uncovered socioeconomic disparities in readmissions rates following SCI. This data may assist vascular neurologists, physicians and healthcare administrators in reducing readmissions after SCI and addressing these disparities. Additionally, our results can guide future studies focusing on the management of this rare entity.
Abstract 4365545: Outcomes of Heart Failure in Muscular Dystrophies in Adults: A Nationwide Analysis in the United States
Jabbar, Ali Bin Abdul, Al-Salahat, Ali, Dilsaver, Danielle B., Ismayl, Mahmoud, Goldsweig, Andrew, Aboeata, Ahmed, Jabbar, Ali Bin Abdul, Al-Salahat, Ali, Dilsaver, Danielle B., Ismayl, Mahmoud, Goldsweig, Andrew, Aboeata, Ahmed

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4365545 Get It

Background: Muscular dystrophies (MDs) may cause heart failure (HF), but outcomes specific to MD-related HF are not well characterized. Research Question: Do the outcomes of HF hospitalizations differ between patients with underlying MDs (MD-HF) vs. patients without MDs (non-MD-HF) in the United States? Methods: Discharge data from HF hospitalizations were abstracted from the Nationwide Readmissions Database (2016-2022) and stratified by the presence or absence of MD (MD-HF vs. non-MD-HF). Logistic regression and lognormal models were estimated to assess differences in inpatient mortality, length of stay (LOS), total costs, complications, and 30-day and 90-day all-cause readmissions. Propensity-score matching (PSM) was used to control baseline differences between the MD-HF and non-MD-HF cohorts. Odds ratios (OR) with associated 95% Confidence intervals (CI) and p-values were reported. Analyses were conducted via SAS v. 9.4, with statistical significance indicated by two-tailed p<.05. Results: 8,466,806 HF hospitalizations were included in the analysis, of which 3688 (0.04%) involved patients with MD. MD-HF hospitalizations involved younger patients (mean age 55.3 vs. 71.3 years, p<0.001) with higher rates of HF with reduced ejection fraction (HFrEF) compared to non-MD-HF hospitalizations (48.1% vs. 34.9%, p<0.001). Compared to non-MD-HF hospitalizations (2.01%), MD-HF hospitalizations (5.82%) were associated with significantly higher odds of inpatient mortality (OR 3.01, 95% CI: 2.03, 4.45); higher complications rate (OR 2.11, 95% CI, 1.77, 2.52) including cardiogenic shock (OR 2.61, 95% CI, 1.90, 3.59), cardiac arrest (OR 2.27, 95% CI, 1.17, 4.41), use of mechanical ventilation (OR 2.23, 95% CI, 1.82, 2.73); higher palliative care consultation (OR 4.52, 95% CI, 3.21, 6.36); as well as more extended hospital LOS (OR 1.18, 95% CI, 1.09, 1.29), higher total costs (OR 1.32, 95% CI, 1.24, 1.41), and higher odds of discharge to rehab facility (OR 2.46, 95% CI, 1.99, 3.03) and home healthcare (OR 1.85, 95% CI, 1.55, 2.21) (all p<0.001). MD was not associated with a significant difference in 30-day (OR 0.94, 95% CI, 0.78, 1.12) and 90-day (OR 0.98, 95% CI, 0.82, 1.17) all-cause readmission rates. Conclusion: MD-HF hospitalizations were associated with higher inpatient mortality, complication rates, resource utilization, discharge to rehab facility and home healthcare, and no difference in readmission rates compared to non-MD-HF hospitalizations.